Human Reproduction · 2003 · 308 citations · 36 references
MedicineEndocrinologyOncologyReproductive EndocrinologyReproductive MedicineWomen's HealthMenstrual CycleOvarian CancerOvarian CycleOvarian DisordersOvarian PhysiologyOvarian ReserveAnti-müllerian Hormone AssessmentAnti-müllerian Hormone TestingBiomarkers Of Ovarian FunctionInhibin BOral Contraceptive PillsOvarian Reserve DepletionOvarian Reserve DiminutionYoung Women
BACKGROUND: Treatment of cancer during childhood may result in loss of primordial follicles from the ovary. METHODS: Ten cancer survivors and 11 controls with regular menstrual cycles, in addition to 10 cancer survivors and 10 controls taking the combined oral contraceptive pill (COCP) were recruited. Subjects were investigated on days 3-5 of a menstrual cycle, or week 3 of COCP administration before and 24 h after administration of 225 IU FSH. RESULTS: Serum FSH levels were elevated in cancer survivors with regular menstrual cycles (7.5 +/- 1.4 versus 4.2 +/- 0.3 IU/l; P = 0.02), while anti-Müllerian hormone (AMH) levels were lower (13.0 +/- 3.0 versus 21.0 +/- 3.4 pmol/l; P < 0.05). Other hormone levels were unchanged. Ovarian volume was smaller in cancer survivors than controls (3.0 +/- 0.5 versus 5.0 +/- 0.8 ml; P < 0.05), but antral follicle count (AFC) was similar. During COCP administration, inhibin B remained undetectable in six cancer survivors after FSH administration, whereas all controls showed a rise in inhibin B levels. The AFC was lower in cancer survivors than in controls (4.2 +/- 0.8 versus 7.2 +/- 0.8; P = 0.02). Ovarian volume was low in both groups, but did not differ between them. CONCLUSIONS: The study results demonstrate both hormonal and biophysical evidence of partial loss of the ovarian reserve in young cancer survivors. This was detected both in women with normal menstrual cycles and during COCP administration.
36
Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause
M. J. Faddy, Roger G. Gosden, A. Gougeon et al. · Human Reproduction · 1992 · 1.4K citations
Medicine, Endocrinology, Gynecology +17
Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve
Ilse A.J. van Rooij · Human Reproduction · 2002 · 950 citations · Full text
Medicine, Endocrinology, Gynecology +17
Antimüllerian hormone serum levels: a putative marker for ovarian aging
Annemarie de Vet, Joop S.E. Laven, Frank H. de Jong et al. · Fertility and Sterility · 2002 · 886 citations · Full text
Medicine, Endocrinology, Gynecology +14